Back to Journals » Drug Design, Development and Therapy » Volume 11

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy

Total article views   Abstract views HTML views PDF downloads Totals
13,048 Dovepress* 8,697 2,398+ 1,323 11,095
PubMed Central* 0 1,953 497 1,953
Totals 8,697 4,351 1,820 13,048
*Since 5 July 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
20 1 0 1 5 13

View citations on PubMed Central and Google Scholar